These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1923768)

  • 21. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway.
    Spies T; Bresnahan M; Bahram S; Arnold D; Blanck G; Mellins E; Pious D; DeMars R
    Nature; 1990 Dec 20-27; 348(6303):744-7. PubMed ID: 2259384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A binding protein to the DNase I hypersensitive site II in HLA-DR alpha gene was identified as NF90.
    Sakamoto S; Morisawa K; Ota K; Nie J; Taniguchi T
    Biochemistry; 1999 Mar; 38(11):3355-61. PubMed ID: 10079079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE; Cooper S; Hangoc G; Chang CH
    Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequences homologous to class II MHC W, X, and Y elements mediate constitutive and IFN-gamma-induced expression of human class II-associated invariant chain gene.
    Brown AM; Barr CL; Ting JP
    J Immunol; 1991 May; 146(9):3183-9. PubMed ID: 1901895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA regions flanking the mouse Ig 3' alpha enhancer are differentially methylated and DNAase I hypersensitive during B cell differentiation.
    Giannini SL; Singh M; Calvo CF; Ding G; Birshtein BK
    J Immunol; 1993 Mar; 150(5):1772-80. PubMed ID: 8436815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel DNase I hypersensitive site within the far upstream region of the human HLA-DRA gene.
    Tomassetti M; Feriotto G; Giacomini P; Giorda E; Bianchi N; Borgatti M; Finotti A; Mischiati C; Gambari R
    Int J Mol Med; 2003 Dec; 12(6):929-34. PubMed ID: 14612968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune responses in MHC class II-deficient mice.
    Grusby MJ; Glimcher LH
    Annu Rev Immunol; 1995; 13():417-35. PubMed ID: 7612230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression.
    Balducci-Silano PL; Suzuki K; Ohta M; Saito J; Ohmori M; Montani V; Napolitano G; Shong M; Taniguchi SI; Pietrarelli M; Lavaroni S; Mori A; Singer DS; Kohn LD
    Endocrinology; 1998 May; 139(5):2300-13. PubMed ID: 9564838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of DNase I-hypersensitive sites in the chromatin of the chicken C/EBPbeta gene reveals multiple cis-regulatory elements.
    Kintscher J; Miethe J; Klempnauer KH
    DNA Cell Biol; 2003 Mar; 22(3):201-8. PubMed ID: 12804118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo modification of major histocompatibility complex class II DRA promoter occupancy mediated by the AIR-1 trans-activator.
    Rigaud G; Paiola F; Accolla RS
    Eur J Immunol; 1994 Oct; 24(10):2415-20. PubMed ID: 7925569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune-privileged embryonic Swiss mouse STO and STO cell-derived progenitor cells: major histocompatibility complex and cell differentiation antigen expression patterns resemble those of human embryonic stem cell lines.
    Koch KS; Son KH; Maehr R; Pellicciotta I; Ploegh HL; Zanetti M; Sell S; Leffert HL
    Immunology; 2006 Sep; 119(1):98-115. PubMed ID: 16836618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic chromatin remodeling in the vicinity of J chain gene for the regulation of two stage-specific genes during B cell differentiation.
    Kang CJ; Oh U; Koshland ME
    Mol Cells; 2000 Feb; 10(1):32-7. PubMed ID: 10774744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The presence of a DNA binding complex correlates with E beta class II MHC gene expression.
    Finn PW; Kara CJ; Van TT; Douhan J; Boothby MR; Glimcher LH
    EMBO J; 1990 May; 9(5):1543-9. PubMed ID: 2328725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNase I-hypersensitive sites in the chromatin of immunoglobulin kappa light chain genes.
    Chung SY; Folsom V; Wooley J
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2427-31. PubMed ID: 6221340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MHC class II proteins contain a potential binding site for the verotoxin receptor glycolipid CD77.
    George T; Boyd B; Price M; Lingwood C; Maloney M
    Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1179-85. PubMed ID: 11838965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
    Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
    Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
    Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
    Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii protein.
    Wang Y; Xu M; Che M; Von Hofe E; Abbas A; Kallinteris NL; Lu X; Liss ZJ; Forman JD; Hillman GG
    Hum Gene Ther; 2005 Feb; 16(2):187-99. PubMed ID: 15761259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA-mediated transfer of major histocompatibility class II I-Ab and I-Abm12 genes into B lymphoma cells: molecular and functional analysis of introduced antigens.
    Ben-Nun A; Choi E; McIntyre KR; Leeman SA; McKean DJ; Seidman JG; Glimcher LH
    J Immunol; 1985 Aug; 135(2):1456-64. PubMed ID: 3925010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.